Diagnostic Service

Molecular Diagnostics.
Precision at the genomic level.

Advanced ancillary testing supporting precision medicine — from tumor profiling to targeted mutation analysis with board-certified interpretation.

Overview

Expert interpretation. Actionable answers.

Molecular diagnostics is transforming how pathologists classify disease and guide therapy. GoldPath’s molecular service integrates advanced genomic testing with traditional histopathology to deliver reports that inform precision treatment decisions.

We offer tumor profiling, targeted mutation analysis, and ancillary testing designed to complement our surgical pathology interpretations. Every result is reviewed in the context of morphology by pathologists who understand both the genomic finding and its clinical implication.

Capabilities

What we deliver.

Every case receives subspecialty-level attention and board-certified interpretation.

Tumor profiling & biomarker analysis
Targeted mutation analysis
Precision medicine support
Integration with histopathology
Board-certified molecular pathologist review
Clinical trial enrollment support
Turnaround-optimized workflows
Physician-friendly result reporting

Physician Partnership

Ready to request a consult?

Our pathologists and physician liaisons are standing by to review your case or onboard your practice.